May 11, 2017 · Doctors, neurology · (No comments)

For a long time, both the public and private sector have spent a considerable amount of money and time in the fight against multiple sclerosis. Nonetheless, a new NIH research has elicited hope after suggesting that stem-cell transplants could be the answer to combating MS.

The study (HALT-MS) revealed that the stem cell transplants of an individual’s blood cells lead to the reduction of long-term symptoms of MS. These outstanding results are produced by both a High-dose immunosuppressive therapy and autologous hematopoietic cell transplant. HALT-MS focused on how 24 clinical subjects ranging between 26 and 52 years reacted to HDIT/HCT. The clinical subjects were individuals whose health was deteriorating despite being under MS treatment.

The study discovered that 69% of the patients who received the treatment once in a five year’s duration did not experience brain lesion or relapse. As such, the HDIT/HCT treatment could prove to be more effective in fighting MS than the commonly prescribed MS drugs even though more research has to be done.

Shiva Gopal Vasishita

Dr. Shiva Gopal Vasishita is a renowned neurologist based in Voorhees, New Jersey. Currently, he is mainly affiliated with the Kennedy Health System Cherry Hill Campus and practices at the Eastern Neurodiagnostic Associates. Dr. Shiva studied at the Government Medical College whereby he graduated in 1979. As an acclaimed neurologist, Shiva Gopal Vasishita is capable of treating various illnesses such as seizures, sleep disorders, epilepsy, stroke and headaches among many others.

Shiva Gopal Vasishita culminated his residency at the Boston City Hospital, which is a top brain injury center that was initially affiliated with Harvard University. In fact, he also trained at Tufts University Medical Center under the supervision of global authorities including John Kelly and Dr. Theodore Munsat. Dr. Shiva Gopal Vasishita holds various certifications and licensure including the NJ State Medical License and American Board of Psychiatry and Neurology.